The Generation Study is a research study which will sequence the genomes of 100,000 newborn babies. The study is being run in partnership with the NHS to understand whether we can improve our ability to diagnose and treat genetic conditions.
The Generation Study will evaluate the utility and feasibility of using genome sequencing to screen newborn babies for a larger number of rare conditions that can then be treated in the NHS.
This aims to improve their health outcomes and quality of life through more timely diagnoses, access to care and treatment.
This study is in addition to, and does not replace the offer of, the routine newborn screening programme and newborn blood spot test.
There are two Trusts in the North East and Yorkshire currently offering the opportunity to take part, and a further four NHS Trusts are in the setup phase with Genomics England.
Find out more about the Generation Study and how to take part here.